Clinical Trials Logo

Chronic Regional Pain Syndrome clinical trials

View clinical trials related to Chronic Regional Pain Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT05188040 Completed - Clinical trials for Distal Radius Fracture

Effectiveness of Virtual Reality in Hand Therapy

Start date: May 16, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of Virtual Reality as an intervention for patients following specific hand injuries will positively affect patients with decreased hand function and reduce pain and improve outcomes. Participants will be recruited from 3 different clinics in central Kentucky.

NCT ID: NCT04913051 Recruiting - Clinical trials for Chronic Regional Pain Syndrome

Interest of Day Hospital Care for Patients With Chronic Regional Pain Syndrome Referred to the Chronic Pain Unit for the First Time

Start date: May 20, 2021
Phase:
Study type: Observational

Chronic Regional Pain Syndrome (CRPS) is a chronic disabling disease. Patients present a variable picture associating pain localized to an articular or peri-articular region, motor and vasomotor disorders and trophic disorders. Its pathophysiology, still poorly understood to this day, results from local inflammatory phenomena complicated by peripheral sensitization and central spinal and cerebral sensitization. The diagnosis is made difficult by the fluctuating nature of the symptoms and the absence of specific complementary examination. The treatment of CRPS is symptomatic and requires multidisciplinary care. CRPS is responsible for an alteration in the patient's quality of life. This pathology has a global impact because it affects not only the biomedical sphere but also the socio-family, professional and psychological spheres. The investigators hypothesize that multidisciplinary intervention in the Day Hospital would improve the quality of life of patients with CRPS. The investigators also think that the passage in Day Hospital would make it possible to improve the pains, the functionality of the affected limb as well as the satisfaction of the patients.

NCT ID: NCT02031211 Withdrawn - CRPS Clinical Trials

TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

Start date: June 2014
Phase: N/A
Study type: Interventional

Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in early CRPS.

NCT ID: NCT00984815 Completed - Clinical trials for Rheumatoid Arthritis

Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment

Start date: September 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of long-term treatment with HZT-501, a fixed-dose combination oral tablet of 800 mg ibuprofen and 26.6 mg famotidine for patients that require long-term NSAID treatment.

NCT ID: NCT00613106 Completed - Clinical trials for Rheumatoid Arthritis

Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)

HZ-CA-304
Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of long-term treatment with HZT-501.